Anti-metastatic Effect of 131I-labeled Buthus martensii Karsch Chlorotoxin in Gliomas

Overview

Journal Int J Mol Med

Specialty Genetics

Date 2018 Oct 2

PMID 30272348

Citations 3

Authors

Shan Wu

Ke Ma

Wen-Li Qiao

Ling-Zhou Zhao

Chang-Cun Liu

Li-Lei Guo

Yan Xing

Mei-Lin Zhu

Jin-Hua Zhao

Affiliations

Soon will be listed here.

Abstract

The present study investigated the underlying molecular mechanism by which Buthus martensii Karsch chlorotoxin (BmK CT) inhibits the invasion and metastasis of glioma cells and the possibility of 131I‑labeled BmK CT (131I‑BmK CT) as a novel targeted agent for the treatment of glioma. The impact of BmK CT with and without 131I radiolabeling on the invasion and metastasis of glioma cells in vitro was studied. Cell viability was assessed using Cell Counting Kit‑8 and plate colony formation assays in order to confirm the cytotoxicity of BmK CT and 131I‑BmK CT at different concentrations. Transwell invasion and wound‑healing assays were conducted in order to investigate the inhibitory effects BmK CT and 131I‑BmK CT on cell migration and invasion. Furthermore, western blotting, ELISA immunofluorescence and a gelatin zymography assay were performed to evaluate changes in the protein expression levels of glioma cells following treatment with BmK CT or 131I‑BmK CT. The results indicated that BmK CT inhibits the invasion and metastasis of glioma cells via regulation of tissue inhibitor of metalloproteinase‑2 expression and that 131I‑BmK CT has the potential to be a novel targeted therapeutic drug for glioma.

Citing Articles

The Significant Therapeutic Effects of Chinese Scorpion: Modern Scientific Exploration of Ion Channels.

Zheng Y, Wen Q, Huang Y, Guo D Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770577 PMC: 11678150. DOI: 10.3390/ph17121735.

Study on the knowledge, attitude and practice of single photon emission computed tomography among oncology healthcare professionals.

Yan M, Cheng X, Li X, Jin X, Dai Y, Li F Front Public Health. 2025; 12:1512686.

PMID: 39758198 PMC: 11695331. DOI: 10.3389/fpubh.2024.1512686.

Harnessing the potency of scorpion venom-derived proteins: applications in cancer therapy.

El-Qassas J, Abd El-Atti M, El-Badri N Bioresour Bioprocess. 2024; 11(1):93.

PMID: 39361208 PMC: 11450130. DOI: 10.1186/s40643-024-00805-0.

Radioimmunotherapy Targeting B7-H3 glioma models enhanced antitumor efficacy by Reconstructing the tumor microenvironment.

Zheng M, Wang Y, Fu F, Zhang K, Wang Y, Zhao S Int J Biol Sci. 2023; 19(13):4278-4290.

PMID: 37705739 PMC: 10496502. DOI: 10.7150/ijbs.87763.

References

Klutz K, Schaffert D, Willhauck M, Grunwald G, Haase R, Wunderlich N . Epidermal growth factor receptor-targeted (131)I-therapy of liver cancer following systemic delivery of the sodium iodide symporter gene. Mol Ther. 2011; 19(4):676-85. PMC: 3070097. DOI: 10.1038/mt.2010.296. View

Fidler I, Kim S, Langley R . The role of the organ microenvironment in the biology and therapy of cancer metastasis. J Cell Biochem. 2006; 101(4):927-36. DOI: 10.1002/jcb.21148. View

Goodenberger M, Jenkins R . Genetics of adult glioma. Cancer Genet. 2012; 205(12):613-21. DOI: 10.1016/j.cancergen.2012.10.009. View

Hou L, Veeravagu A, Hsu A, Tse V . Recurrent glioblastoma multiforme: a review of natural history and management options. Neurosurg Focus. 2006; 20(4):E5. DOI: 10.3171/foc.2006.20.4.2. View

Su Y, Wan D, Song W . Dryofragin inhibits the migration and invasion of human osteosarcoma U2OS cells by suppressing MMP-2/9 and elevating TIMP-1/2 through PI3K/AKT and p38 MAPK signaling pathways. Anticancer Drugs. 2016; 27(7):660-8. DOI: 10.1097/CAD.0000000000000381. View

Zhao J, Qiao W, Zhang Y, Shao X . Preparation and in vitro evaluation of 131I-BmK CT as a glioma-targeted agent. Cancer Biother Radiopharm. 2010; 25(3):353-9. DOI: 10.1089/cbr.2009.0704. View

Steeg P . Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 2006; 12(8):895-904. DOI: 10.1038/nm1469. View

Shimoda M, Jackson H, Khokha R . Tumor suppression by stromal TIMPs. Mol Cell Oncol. 2016; 3(3):e975082. PMC: 4909426. DOI: 10.4161/23723556.2014.975082. View

Hockaday D, Shen S, Fiveash J, Raubitschek A, Colcher D, Liu A . Imaging glioma extent with 131I-TM-601. J Nucl Med. 2005; 46(4):580-6. View

10.

Mamelak A, Rosenfeld S, Bucholz R, Raubitschek A, Nabors L, Fiveash J . Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma. J Clin Oncol. 2006; 24(22):3644-50. DOI: 10.1200/JCO.2005.05.4569. View

11.

Stetler-Stevenson W . Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am J Pathol. 1996; 148(5):1345-50. PMC: 1861572. View

12.

Kayano D, Kinuya S . Current Consensus on I-131 MIBG Therapy. Nucl Med Mol Imaging. 2018; 52(4):254-265. PMC: 6066492. DOI: 10.1007/s13139-018-0523-z. View

13.

Kim S, Kang S, Park H, Ban J, Oh C, Chung J . Meta-analysis of association of the matrix metalloproteinase 2 (-735 C/T) polymorphism with cancer risk. Int J Clin Exp Med. 2016; 8(10):17096-101. PMC: 4694202. View

14.

Lyons S, ONeal J, Sontheimer H . Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin. Glia. 2002; 39(2):162-73. DOI: 10.1002/glia.10083. View

15.

Kessenbrock K, Plaks V, Werb Z . Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010; 141(1):52-67. PMC: 2862057. DOI: 10.1016/j.cell.2010.03.015. View

16.

Figueira R, Gomes L, Neto J, Silva F, Silva I, Sogayar M . Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential. BMC Cancer. 2009; 9:20. PMC: 2631003. DOI: 10.1186/1471-2407-9-20. View

17.

Soroceanu L, Gillespie Y, Khazaeli M, Sontheimer H . Use of chlorotoxin for targeting of primary brain tumors. Cancer Res. 1998; 58(21):4871-9. View

18.

Zhang X, Liu D, Luan Z, Zhang F, Liu X, Zhou W . Efficacy of radioiodine therapy for treating 20 patients with pulmonary metastases from differentiated thyroid cancer and a meta-analysis of the current literature. Clin Transl Oncol. 2017; 20(7):928-935. PMC: 5996003. DOI: 10.1007/s12094-017-1792-1. View

19.

Cuddapah V, Robel S, Watkins S, Sontheimer H . A neurocentric perspective on glioma invasion. Nat Rev Neurosci. 2014; 15(7):455-65. PMC: 5304245. DOI: 10.1038/nrn3765. View

20.

Fu Y, An N, Chan K, Wu Y, Zheng S, Liang A . A model of BmK CT in inhibiting glioma cell migration via matrix metalloproteinase-2 from experimental and molecular dynamics simulation study. Biotechnol Lett. 2011; 33(7):1309-17. DOI: 10.1007/s10529-011-0587-7. View